$1.19
-0.11-8.46%

The average analyst price target for Myomo is $7.75. Of 4 analysts, 4 rate it Buy. Targets range from $5 to $10.50. The latest change came on Aug 27, 2026, when Ascendiant Capital raised its price target on Myomo from $10 to $10.50 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months